Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
-35.9%/yr
vs +31.0%/yr prior
5Y CAGR
+3.8%/yr
Recent deceleration
Acceleration
-67.0pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.83M | -58.2% |
| 2024 | $18.72M | -40.1% |
| 2023 | $31.25M | +5.0% |
| 2022 | $29.75M | +340.1% |
| 2021 | $6.76M | +4.3% |
| 2020 | $6.48M | +53.3% |
| 2019 | $4.23M | -58.1% |
| 2018 | $10.09M | +499.6% |
| 2017 | $1.68M | - |
| 2016 | $0.00 | - |